DCF Model

Business

Cullen/Frost Bankers Surpasses Q4 Expectations, Expands Buyback Amid Strong Texas Growth

Cullen/Frost Bankers (NYSE: CFR) reported robust fourth-quarter results, beating analyst estimates on earnings and revenue. The Texas-based regional bank also announced a new $300 million share repurchase program and raised its guidance, fueling a debate on whether its current valuation fully reflects its growth trajectory.

Jan 30, 2026

Business

Hershey Stock in the Spotlight: Earnings Optimism and Spicy New Gummies Fuel Investor Interest

Hershey (HSY) shares are drawing renewed attention from Wall Street as upbeat earnings sentiment converges with the launch of its innovative Jolly Rancher Heat Wave Gummies. While recent momentum is strong, valuation metrics present a complex picture for the iconic confectioner.

Jan 30, 2026

Business

Honeywell Accelerates Aerospace Spin-Off to Q3 2026 Amid Record Orders, Reshaping Investor Outlook

Honeywell International posts a robust Q4 with record orders and backlog, while announcing an accelerated timeline to spin off its core Aerospace business as a standalone public company by late 2026, a move set to redefine its investment profile.

Jan 30, 2026

Business

Moody's Doubles Down on Risk Tech as Private Credit Faces Heightened Scrutiny

Moody's Corporation bolsters its risk analytics arsenal with strategic acquisitions of Numerated Growth Technologies and CAPE Analytics, positioning itself at the center of a private credit market under the regulatory microscope.

Jan 30, 2026

Business

Amazon Axes Over 500 Jobs in Sacramento as It Shutters Fresh and Go Stores Nationwide

Amazon is closing its cashier-less Fresh and Go grocery stores across the U.S., resulting in more than 500 layoffs in the Sacramento region alone. The tech giant says it will now concentrate its grocery efforts on expanding its Whole Foods Market chain.

Jan 30, 2026

Business

Heineken Taps Into Global Fandom Culture with 'Fans Have More Fun' Platform

Heineken launches a global marketing initiative celebrating shared passions in sports and music, aiming to foster real-world connections amid declining U.S. sales and a competitive import beer market.

Jan 30, 2026

Business

Beyond Jabil: Why This Market Darling May Disappoint, and a Digital Ad Play to Watch

While Jabil's stock has mirrored the S&P 500's recent gains, a closer look reveals underlying concerns over growth, profitability, and cash flow. We analyze the risks and spotlight a more compelling alternative in the digital advertising space.

Jan 30, 2026

Business

29Metals Secures A$150m Lifeline, Shares Jump 9% – Is the Turnaround Now on Firmer Ground?

The ASX-listed miner's heavily discounted rights issue aims to shore up its balance sheet after a period of steep losses, but analysts are divided on whether the fresh capital marks a new beginning or merely delays deeper challenges.

Jan 30, 2026

Business

Netflix's Slowing Growth Outlook Sends Shares Tumbling, Despite Ad Revenue Surge

Netflix shares face pressure as the streaming giant's 2026 revenue guidance signals a significant growth deceleration, even with its advertising business poised to double. Investor concerns are compounded by a potential multi-billion dollar acquisition.

Jan 30, 2026

Business

AI's Relentless Pace: Tech Giants Forced to Choose Between Evolution and Obsolescence

As artificial intelligence reshapes the competitive landscape, tech leaders face a stark choice: disrupt their own profitable core businesses or risk being left behind. New financial results from Microsoft, Meta, and Tesla reveal the high-stakes strategies—and market reactions—defining this pivotal moment.

Jan 30, 2026

Business

SciDev's Turnaround Story: From Losses to Profitability as Capital Efficiency Rises

The Australian chemicals company SciDev (ASX:SDV) is showing early signs of a financial transformation, with its return on capital employed turning positive after years of losses. While its current returns still lag the industry average, a significant increase in capital deployment suggests the firm is aggressively reinvesting for growth.

Jan 30, 2026

Business

USA Rare Earth Secures Major CHIPS Act Funding, Prompting Analyst Price Target Surge

USA Rare Earth Inc. (NASDAQ: USAR) sees its price target significantly raised by Canaccord Genuity and Benchmark following a landmark $1.6 billion commitment from the U.S. CHIPS Program, accelerating its plans to build a domestic rare earth supply chain.

Jan 30, 2026

Business

Beyond the Mandate: Calls Grow for Central Banks to Refocus on Inflation Fight

As the Bank of England prepares for a leadership transition in 2028, a debate ignited by former Fed governor Kevin Warsh gains traction: should central banks shed ancillary roles and return to their core mission of price stability?

Jan 30, 2026

Business

Lido Launches Customizable stVaults, Drawing Linea and Nansen as First Major Adopters

Ethereum's dominant liquid staking protocol, Lido, has launched its modular stVaults on mainnet, enabling protocols and institutions to create tailored staking solutions. Consensys's Linea and analytics firm Nansen were among the first to deploy, signaling a shift towards more flexible staking infrastructure.

Jan 30, 2026

Business

WhiteFiber Stock in Focus After Analyst Adjustment and Major New Data Center Deal

Despite a trimmed price target from B. Riley, WhiteFiber Inc. (WYFI) secures a pivotal 10-year colocation agreement expected to generate $865 million, spotlighting its role in the expanding AI infrastructure sector.

Jan 30, 2026

Business

Northland Cuts Bitdeer Price Target to $25 After December Update, Maintains Bullish Stance

Northland Capital has revised its price target for Bitdeer Technologies (BTDR) downward to $25, citing a more conservative valuation approach following the company's latest operational update. The firm, however, reaffirmed its Outperform rating, signaling continued confidence in the blockchain and high-performance computing firm's long-term strategy.

Jan 30, 2026

Business

Analysts Bullish on Ovid Therapeutics as Pipeline Progresses, Penny Stock Gains Attention

Ovid Therapeutics (NASDAQ: OVID) has garnered analyst optimism following positive Phase 1 trial results for its novel neurological drug candidate and a recent 'Outperform' initiation. The biotech firm is now shifting focus to a more potent oral therapy, with key regulatory milestones ahead.

Jan 30, 2026

Business

Morgan Stanley Downgrades Gogo Outlook as 5G Rollout Meets Industry Uncertainty

Analysts remain divided on Gogo Inc.'s trajectory as the in-flight connectivity provider navigates its 5G network launch against a backdrop of strategic shifts and evolving satellite technology debates.

Jan 30, 2026

Business

Century Therapeutics Gains Analyst Confidence with Extended Cash Runway and Key IND Submission on Horizon

Piper Sandler raises its price target for Century Therapeutics (IPSC), highlighting the biotech firm's robust financial position extending into 2029 and an upcoming Investigational New Drug application for its lead cell therapy candidate, CNTY-813.

Jan 30, 2026

Business

Maxim Group Reiterates Bullish Stance on Strive (ASST), Sees 50% Upside to $1.50 Target

Investment firm Maxim Group reaffirms its Buy rating and $1.50 price target for Strive Inc., following the company's transformative acquisition of Semler Scientific, which positions it as a major corporate Bitcoin holder and expands its healthcare tech footprint.

Jan 30, 2026